Moving Ibogaine Toward Pharmaceutical Standards
Pharmogaine was created with a desire to support the transition of ibogaine from an inconsistent gray-market environment toward verifiable, tested, standardized and regulated pharmaceutical production.
Availability Is Not the Same as Pharmaceutical Development
Ibogaine is used in environments where product identity, manufacturing standards, analytical testing and regulatory oversight can vary. Pharmogaine exists to make the case for a more accountable path.
The goal is not simply greater availability. It is a future in which ibogaine intended for medical development can be characterized, consistently produced, tested and evaluated within appropriate pharmaceutical and regulatory frameworks.
Three Principles Guide the Mission
Quality
Support defined standards for identity, purity, consistency, testing and manufacturing.
Evidence
Encourage clinical development built around characterized products and reliable research.
Oversight
Promote development within appropriate medical, pharmaceutical and regulatory systems.
From Gray Market to Verifiable Medicine
Pharmogaine supports the idea that ibogaine should move toward the standards expected of modern pharmaceutical development: documented production, analytical testing, reproducibility, clinical evidence, safety monitoring and regulatory review.
This is a long-term development objective, not a claim that Pharmogaine currently manufactures, distributes, prescribes or administers ibogaine.
An Initiative Focused on Pharmaceutical Development
Pharmogaine Advocates For
- pharmaceutical-grade production
- analytical verification
- standardized manufacturing
- clinical evidence
- regulatory oversight
- responsible medical development
Pharmogaine Does Not Provide
- medical treatment
- prescriptions
- patient referrals
- dosing advice
- ibogaine products
- clinic recommendations
A More Accountable Path for Ibogaine
Pharmogaine exists to make the case for moving ibogaine toward the quality, evidence, manufacturing controls and regulatory oversight expected of a modern pharmaceutical medicine.